Search research articles
Contact Us
Filters
Showing results (791-800 of 1,041) with videos related to
Page
of 105
Sort By:
Journal of the National Cancer Institute
|
March 7, 2015
The contributions of breast density and common genetic variation to breast cancer risk
Celine M Vachon, V Shane Pankratz, Christopher G Scott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
Alexander Hein, Andreas D Hartkopf, Julius Emons, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
Volkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Andreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.
Geburtshilfe Und Frauenheilkunde
|
August 29, 2017
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry
Markus Wallwiener, Felix Heindl, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde
|
November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
Cancers
|
October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Laura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
December 2, 2020
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
Elena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Cancers
|
December 23, 2018
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Michael P Lux, Naiba Nabieva, Andreas D Hartkopf, et al.
Breast Cancer Research and Treatment
|
September 26, 2014
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Jessica Salmen, Julia Neugebauer, Peter A Fasching, et al.
Page
of 105
Search research articles
Search
Showing results (791-800 of 1,041) with videos related to
Sort By:
Page
of 105
Journal of the National Cancer Institute
|
March 7, 2015
The contributions of breast density and common genetic variation to breast cancer risk
Celine M Vachon, V Shane Pankratz, Christopher G Scott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
Alexander Hein, Andreas D Hartkopf, Julius Emons, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
Volkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Andreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.
Geburtshilfe Und Frauenheilkunde
|
August 29, 2017
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry
Markus Wallwiener, Felix Heindl, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde
|
November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
Cancers
|
October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Laura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
December 2, 2020
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
Elena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Cancers
|
December 23, 2018
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Michael P Lux, Naiba Nabieva, Andreas D Hartkopf, et al.
Breast Cancer Research and Treatment
|
September 26, 2014
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Jessica Salmen, Julia Neugebauer, Peter A Fasching, et al.
Page
of 105